These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22679309)

  • 1. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
    Eldrup N; Kragelund C; Steffensen R; Nordestgaard BG
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):677-83. PubMed ID: 21194909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
    O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
    Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease.
    Roos M; von Eynatten M; Heemann U; Rothenbacher D; Brenner H; Breitling LP
    Am J Cardiol; 2010 Jun; 105(12):1666-72. PubMed ID: 20538112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.
    Tso AW; Xu A; Sham PC; Wat NM; Wang Y; Fong CH; Cheung BM; Janus ED; Lam KS
    Diabetes Care; 2007 Oct; 30(10):2667-72. PubMed ID: 17620449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention.
    Takagi W; Miyoshi T; Doi M; Okawa K; Nosaka K; Nishibe T; Matsuo N; Hirohata S; Ito H
    BMC Cardiovasc Disord; 2017 Oct; 17(1):258. PubMed ID: 29017449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
    J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
    Grandi NC; Breitling LP; Hahmann H; Wüsten B; März W; Rothenbacher D; Brenner H
    Heart; 2011 Aug; 97(15):1215-21. PubMed ID: 21586795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension.
    Lankeit M; Dellas C; Panzenböck A; Skoro-Sajer N; Bonderman D; Olschewski M; Schäfer K; Puls M; Konstantinides S; Lang IM
    Eur Respir J; 2008 May; 31(5):1024-9. PubMed ID: 18256058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease.
    Grandi NC; Brenner H; Hahmann H; Wüsten B; März W; Rothenbacher D; Breitling LP
    Heart; 2012 Jun; 98(12):926-33. PubMed ID: 22301505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure.
    Tomaschitz A; Pilz S; Ritz E; Morganti A; Grammer T; Amrein K; Boehm BO; März W
    Eur Heart J; 2011 Nov; 32(21):2642-9. PubMed ID: 21606079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.
    Tonelli M; Sacks F; Pfeffer M; Gao Z; Curhan G;
    Circulation; 2005 Oct; 112(17):2627-33. PubMed ID: 16246962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitive C-reactive protein predicts outcome after coronary artery bypass.
    Wang J; Zheng Z; Yang L; Zhang L; Fan H; Hu S
    Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):525-33. PubMed ID: 23087294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis.
    Yeung DC; Xu A; Cheung CW; Wat NM; Yau MH; Fong CH; Chau MT; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1796-802. PubMed ID: 17510463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.